Schedule 13D ownership disclosure
SKYE BIOSCIENCE INC
Common Stock, par value $0.001 · CUSIP: 83086J200
Event date: 2024-12-17
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- 5AM Partners VII, LLCReported CIK 0001873545
Shares: 9,872,599.00 · Class: 30.8%
- 5AM Ventures VII, L.P.Reported CIK 0001844435
Shares: 9,872,599.00 · Class: 30.8%
- 5AM Partners II, LLCReported CIK 0001555952
Shares: 1,745,962.00 · Class: 5.8%
- 5AM Ventures II, L.P.Reported CIK 0001386509
Shares: 1,679,685.00 · Class: 5.5%
- 5AM Co-Investors II, L.P.Reported CIK 0001390376
Shares: 66,277.00 · Class: 0.2%
- Andrew J. SchwabReported CIK 0001598549
Shares: 11,696,895.00 · Class: 36.4%
- Kush ParmarReported CIK 0001664281
Shares: 9,872,599.00 · Class: 30.8%
- John D. DiekmanReported CIK 0001240357
Shares: 1,745,962.00 · Class: 5.8%
- Scott M. RocklageReported CIK 0001219014
Shares: 1,745,962.00 · Class: 5.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-24-029910
- Form type
- SCHEDULE 13D/A
- Filer
- 5AM Partners VII, LLC
- CIK
- CIK 1873545
- Filed
- Dec 19, 2024
- Reporting period
- Dec 17, 2024
- Description
- Schedule 13D beneficial ownership